跳转至内容
Merck
CN

RAB0537

人FABP2 /脂肪酸结合蛋白，肠道ELISA试剂盒

for serum, plasma, cell culture supernatants and urine

别名:

FABP2 ELISA 试剂盒, 肠道 FABP2 检测

登录 查看组织和合同定价。

选择尺寸

关于此项目

NACRES:
NA.32
UNSPSC Code:
41116158
Gene information:
human ... FABP2(2169)
Input:
sample type plasma
sample type serum
sample type urine
sample type cell culture supernatant(s)
Species reactivity:
human
Storage temp.:
−20°C
Shipped in:
wet ice

主要文件

查看所有文档
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

species reactivity

human

packaging

kit of 96 wells (12 strips x 8 wells)

technique(s)

ELISA: suitable

input

sample type plasma
sample type serum
sample type urine
sample type cell culture supernatant(s)

assay range

inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 25 pg/mL

detection method

colorimetric

shipped in

wet ice

storage temp.

−20°C

Gene Information

human ... FABP2(2169)

相关类别

General description

该试剂盒提供的抗体对可检测血清、血浆、细胞培养上清液和尿液中的人肠型脂肪酸结合蛋白。

脂肪酸结合蛋白(FABP2)是由定位于人类染色体4q28–q31的基因编码的细胞内蛋白质。主要分布于肠上皮细胞。FABP2基因编码肠型FABP蛋白(I-FABP)。

Application

仅供研究使用。不可用于诊断操作。
请参考附带的一般ELISA试剂盒操作程序（夹心、竞争性 & 间接ELISA）

Biochem/physiol Actions

脂肪酸结合蛋白(FABP2)在膳食长链脂肪酸的吸收和细胞内转运中起着重要作用。也支持脂肪酸代谢。FABP2可能是糖尿病和胰岛素抵抗的候选基因。还参与脂质代谢和脂肪生成。

Other Notes

本产品提供样本检验报告。
请在批号对应的文本框中输入样品 一词。

试剂盒组分也可单独购买

产品编号
说明
化学品安全说明书
  • RABTMB3ELISA Colorimetric TMB Reagent (HRP Substrate, Item H)化学品安全说明书
  • RABSTOP3ELISA Stop Solution (Item I)化学品安全说明书
  • RABELADBELISA 5X Assay/Sample Diluent Buffer B (Item E1)化学品安全说明书
  • RABELADCELISA 1X Assay/Sample Diluent Buffer C (Item L)化学品安全说明书
  • RABWASH420X Wash Buffer (Item B)化学品安全说明书

pictograms

Corrosion
GHS05

signalword

Warning

hcodes

H290

Hazard Classifications

Met. Corr. 1

存储类别

8A - Combustible corrosive hazardous materials

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0803J0394
0120J0394
0117J0394
1220I0394
1228I0394

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Natalia Drabińska et al.
Nutrients, 12(6) (2020-06-14)
Abnormalities in the intestinal barrier are a possible cause of celiac disease (CD) development. In animal studies, the positive effect of prebiotics on the improvement of gut barrier parameters has been observed, but the results of human studies to date
Daniela Paganini et al.
Gut, 66(11), 1956-1967 (2017-08-05)
Iron-containing micronutrient powders (MNPs) reduce anaemia in African infants, but the current high iron dose (12.5 mg/day) may decrease gut In a 4-month, controlled, double-blind trial, we randomised Kenyan infants aged 6.5-9.5 months (n=155) to receive daily (1) a MNP without
Christopher Storm-Larsen et al.
AIDS (London, England), 33(4), 645-653 (2018-12-12)
Translocation of microbial products such as lipopolysaccharides (LPS) from the gut may contribute to chronic inflammation in HIV-infected individuals. Recent studies indicate that differences in degree of acylation of gut-bacterial-derived LPS may explain variable immune effects, with hexa-acylated rather than
A novel approach to the nutrigenetics and nutrigenomics of obesity and weight management.
Joffe Y T and Christine A H
Current Oncology Reports, 18(7), 43-43 (2016)
Derrick R Samuelson et al.
PLoS pathogens, 13(6), e1006426-e1006426 (2017-06-13)
Chronic alcohol consumption perturbs the normal intestinal microbial communities (dysbiosis). To investigate the relationship between alcohol-mediated dysbiosis and pulmonary host defense we developed a fecal adoptive transfer model, which allows us to investigate the impact of alcohol-induced gut dysbiosis on
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持